WEF-001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for WEF-001, covering 2026-01-29 to 2026-01-29. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours. [Phase 1, Phase 2]